Literature DB >> 2104938

Efficient tumor suppression by glioma-specific murine cytotoxic T lymphocytes transfected with interferon-gamma gene.

S Miyatake1, K Nishihara, H Kikuchi, J Yamashita, Y Namba, M Hanaoka, Y Watanabe.   

Abstract

We have recently shown that exogenous expression of the mouse interferon-gamma (IFN-gamma) gene augmented the cell-killing potential of a line of cytotoxic T lymphocytes (CTLs) specific against a murine glioma line (203-glioma). In the present work, we further investigated the in vivo antitumor effects of the E gamma-6 and E gamma-9 sublines of this CTL line transfected with the IFN-gamma gene. Using the Winn assay to test the neutralization of subcutaneous gliomas, we determined that these CTL sublines were more effective than the E-4 parent CTL line and that suppression of the tumor growth was dependent on the number of effector cells (CTLs). Moreover, intravenous injection of E gamma-9 cells was more effective in suppressing the tumor growth than intravenous injection of E-4 cells. These results suggest that transfection of antitumor effector cells with the IFN-gamma gene could improve the efficacy of adoptive immunotherapy against cancer.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2104938     DOI: 10.1093/jnci/82.3.217

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  6 in total

1.  Ex vivo expansion of tumor-draining lymph node cells using compounds which activate intracellular signal transduction. II. Cytokine production and in vivo efficacy of glioma-sensitized lymphocytes.

Authors:  C D Rice; N G Baldwin; R T Biron; H D Bear; R E Merchant
Journal:  J Neurooncol       Date:  1997-03       Impact factor: 4.130

2.  Correlation of the therapeutic effect of activated tumor-draining lymph node cells with specific interferon-gamma production in vitro.

Authors:  S Sameshima; K Sakai; H Nagawa; N Tsuno; J Kitayama; T Muto
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

3.  Brain Tumor Working Group Report on the 9th International Conference on Brain Tumor Research and Therapy. Organ System Program, National Cancer Institute.

Authors:  D F Deen; A Chiarodo; E A Grimm; J R Fike; M A Israel; L E Kun; V A Levin; L J Marton; R J Packer; A E Pegg
Journal:  J Neurooncol       Date:  1993-06       Impact factor: 4.130

4.  CD8(+) T cells armed with retrovirally transduced IFN-gamma.

Authors:  Christian Becker; Stefan Lienenklaus; Jadwiga Jablonska; Heike Bauer; Siegfried Weiss
Journal:  J Mol Med (Berl)       Date:  2006-11-16       Impact factor: 4.599

5.  Gamma interferon transduced 9L gliosarcoma. Cytokine gene therapy and its relevance to cellular therapy with alloreactive cytotoxic T lymphocytes.

Authors:  David B Paul; Susana B Read; Nisha V Kulprathipanja; German G Gomez; B K Kleinschmidt-DeMasters; Patric M Schiltz; Carol A Kruse
Journal:  J Neurooncol       Date:  2003 Aug-Sep       Impact factor: 4.130

6.  Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes.

Authors:  R J Barth; J J Mulé; P J Spiess; S A Rosenberg
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.